Navigation Links
Journal Chest: April news briefs
Date:4/7/2009

ASTHMA EPISODES DECREASE WITH REDUCED ETS EXPOSURE

Environmental tobacco smoke (ETS) exposure is associated with poor asthma outcomes in children. However, a new study shows that reducing exposure to ETS may improve asthma outcomes. University of Alabama researchers followed 240 children with asthma who were either receiving usual care or supervised asthma therapy. No smoking cessation counseling or ETS exposure education was provided to caregivers; however, children were given 20 minutes of asthma education that incorporated discussion on the avoidance of asthma triggers, including ETS. Asthma morbidity and ETS exposure were collected from caregivers via telephone interviews at baseline and at 1-year follow-up. Among children whose ETS exposure decreased from baseline, fewer hospitalizations and ED visits were reported. Additionally, these children were 48 percent less likely to experience an episode of poor asthma control. These findings emphasize the importance of ETS exposure reduction as a mechanism to improve asthma control and morbidity. This study is published in the April issue of the journal CHEST.

FOOT SURGERY PATIENTS RUN LOW RISK FOR BLOOD CLOTS

Although recent surgery is a risk factor for deep vein thrombosis (DVT) or blood clots, a new study suggests that patients who undergo podiatric surgery may have a relatively low risk for thrombolytic events. In a 5-year retrospective analysis, researchers from Kaiser Permanente Center for Health Research reviewed the charts of 7,264 patients who underwent podiatric surgical procedures. Of the 16,804 total procedures recorded, overall incidence of post-procedure venous thromboembolism (VTE) was 0.30 percent. The incidence of VTE increased slightly with the presence of risk factors, including prior VTE, use of hormone replacement therapy, and obesity. Researchers conclude that the low overall risk of VTE in podiatric surgery suggests routine prophylaxis is not warranted. This study is published in the April issue of the journal CHEST.

RARE LUNG DISEASE PREVALENT IN TENNESSEE APPALACHIA

New research confirms that blastomycosis, an uncommon lung disease caused by a fungus, continues to be a problem in the Appalachian area of northeastern Tennessee. The disease, characterized by flu-like symptoms, is most often reported in people with exposures to wooded sites (e.g., farmers, forestry workers, hunters, and campers). In a retrospective study, researchers from East Tennessee State University found that blastomycosis was still prevalent in the northeastern Tennessee area (n=67), increasing slightly from the research team's previous findings from 1980 to 1995 (n=55). Researchers speculate that, as the region continues to experience a population growth, additional cases of the disease are to be expected. This study is published in the April issue of the journal CHEST.


'/>"/>

Contact: Jennifer Stawarz
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. Medical Journal Praises VA Electronic Health Record
2. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
3. In Five-Part Video Series, Yoga Journal Hires The Inappropriate Yoga Guy as Editor
4. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
5. Response to Association Between Hospital-Reported Leapfrog Safe Practices Scores and Inpatient Mortality, Journal of the American Medical Association (JAMA); April 1, 2009
6. Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology
7. New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health
8. Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy
9. U of Minnesota professor authors report the state of health care journalism
10. Journal of American College of Surgeons finds lung transplantation should be used in older patients
11. Journal Chest: March news briefs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will ... Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in the ... beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment ...
(Date:12/2/2016)... CO (PRWEB) , ... December 02, 2016 , ... Advanced ... announced it has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief ... for Advanced, Inc. , Jason brings extensive financial and operational leadership experience to ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... The annual ... Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who ... C) or prescription drug plan (Part D) need to make changes during this period ...
(Date:12/2/2016)... NY (PRWEB) , ... December 02, 2016 , ... ... an inspirational interview of two ostomy patients, standing as living proof that attitude ... suffer from digestive diseases and issues that spike around the holidays. This campaign ...
(Date:12/2/2016)... ... 2016 , ... Mediaplanet is proud to announce the launch ... innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians ... years in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Dec. 2, 2016  Eli Lilly and Company (NYSE: ... for 2017 and provide updated financial guidance for 2016 ... a conference call on that day with the investment ... guidance. The conference call will begin at ... can access a live webcast of the conference call ...
(Date:12/2/2016)... bioLytical Laboratories, ein Weltführer bei schnellen Tests für Infektionskrankheiten, hat sein ... eingeführt. Continue Reading ... ... , ... ) bioLytical wurde durch die Clinton Health Access ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific ... definitive agreement to acquire certain manufacturing assets and capabilities ... (TSX: NVC) advanced biological tissue business, as well as ... of $75 million in cash. The Neovasc advanced biological ... including the Boston Scientific Lotus™ Valve System. * ...
Breaking Medicine Technology: